How much did Resmed achieve in EBIT for the current year?
In the current year, Resmed has achieved an EBIT of 1.41 B USD.
Resmed EBIT 2024
Resmed EBIT
1.41 B USD
Resmed Dividend yield
0.84 %
Ticker
RMD
ISIN
US7611521078
WKN
895878
In 2024, Resmed's EBIT was 1.41 B USD, a 21.96% increase from the 1.15 B USD EBIT recorded in the previous year.
The Resmed EBIT history
| YEAR | EBIT (undefined USD) |
|---|---|
| 2029e | - |
| 2028e | 2.12 |
| 2027e | 1.96 |
| 2026e | 1.68 |
| 2025e | 1.55 |
| 2024e | 1.41 |
| 2023 | 1.15 |
| 2022 | 1 |
| 2021 | 0.92 |
| 2020 | 0.81 |
| 2019 | 0.64 |
| 2018 | 0.56 |
| 2017 | 0.46 |
| 2016 | 0.44 |
| 2015 | 0.41 |
| 2014 | 0.41 |
| 2013 | 0.38 |
| 2012 | 0.29 |
| 2011 | 0.27 |
| 2010 | 0.24 |
| 2009 | 0.19 |
| 2008 | 0.15 |
| 2007 | 0.09 |
| 2006 | 0.13 |
| 2005 | 0.11 |
| 2004 | 0.09 |
Resmed Aktienanalyse
What does Resmed do?
ResMed Inc. is a global leading provider of medical devices for the treatment of sleep disorders and respiratory diseases. The company was founded in Australia by Peter Farrell, a former employee of the University of New South Wales, in 1989. Today, ResMed is headquartered in San Diego, California, and employs over 7,500 people worldwide. Business model: ResMed's business model is based on providing medical products and solutions for the treatment of sleep apnea and other respiratory diseases. The company develops and distributes masks, devices, and accessories that help patients breathe better and achieve restful sleep. ResMed also offers cloud-based software solutions and services to assist doctors and sleep labs in diagnosing and monitoring patients. Products and divisions: ResMed's product range can be divided into four main divisions: Sleep & Respiratory Care, Software as a Service (SaaS), Technologies, and Dental Solutions. Sleep & Respiratory Care: In this division, ResMed offers a wide range of masks, devices, and accessories for the treatment of sleep apnea and other respiratory diseases. The most well-known products include the AirSense and AirMini devices, equipped with Automatic Sleep Detection and AutoSet algorithm to optimize respiratory pressure. ResMed also offers a range of CPAP masks, nasal and full face masks, as well as nasal pillow masks. Software as a Service (SaaS): ResMed's cloud-based software solutions and services are offered under the brand AirView. They include diagnostic tools, patient monitoring systems, and analysis tools. AirView allows doctors to access their patients' medical data captured by ResMed devices and monitor this data in real-time. Technologies: ResMed's Technologies division focuses on the development of advanced sensors for respiratory and sleep monitoring. Products include the S+, a smart sleep tracking system that operates without direct body contact, and the Reveal-LTE, an implant for monitoring heart and respiratory rates in patients with heart failure. Dental Solutions: ResMed has also developed products for dentistry to assist patients with mild to moderate upper airway obstruction. Products include the Narval CC, a custom-made dental device for the treatment of snoring and sleep apnea, and the Tap Pap nasal pillow oral appliance, a non-invasive mouthguard. Conclusion: ResMed is a leading provider of medical devices and solutions for the treatment of sleep apnea and other respiratory diseases. The company offers innovative products and technologies that help patients breathe better and achieve restful sleep. ResMed's cloud-based software solutions enable doctors to monitor their patients' health in real-time and develop effective diagnosis and treatment strategies. With its wide range of products, innovation, and highly qualified team of scientists, engineers, and medical professionals, ResMed will continue to play an important role in the healthcare industry. Resmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Resmed's EBIT
Resmed's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Resmed's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Resmed's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Resmed’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Resmed Stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Resmed.
How has the EBIT of Resmed developed in recent years?
The EBIT of Resmed has increased by 21.962% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Resmed?
The EBIT of Resmed is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Resmed pay?
Over the past 12 months, Resmed paid a dividend of 1.84 USD . This corresponds to a dividend yield of about 0.84 %. For the coming 12 months, Resmed is expected to pay a dividend of 2.11 USD.
What is the dividend yield of Resmed?
The current dividend yield of Resmed is 0.84 %.
When does Resmed pay dividends?
Resmed pays a quarterly dividend. This is distributed in the months of September, December, March, June.
How secure is the dividend of Resmed?
Resmed paid dividends every year for the past 0 years.
What is the dividend of Resmed?
For the upcoming 12 months, dividends amounting to 2.11 USD are expected. This corresponds to a dividend yield of 0.97 %.
In which sector is Resmed located?
Resmed is assigned to the 'Health' sector.
Wann musste ich die Aktien von Resmed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Resmed from 6/13/2024 amounting to 0.48 USD, you needed to have the stock in your portfolio before the ex-date on 5/8/2024.
When did Resmed pay the last dividend?
The last dividend was paid out on 6/13/2024.
What was the dividend of Resmed in the year 2023?
In the year 2023, Resmed distributed 1.72 USD as dividends.
In which currency does Resmed pay out the dividend?
The dividends of Resmed are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Resmed stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Resmed
Our stock analysis for Resmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Resmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
